Get started
Award

R01 AG075336

Funded outputs count: 65
Funder award ID: R01 AG075336
OpenAlex ID: G1099014294
Attention‐deficit/hyperactivity disorder polygenic risk score and incidence of cognitive impairment in older adults: A prospective multicohort study
2026 · Douglas Teixeira Leffa, Guilherme Bauer‐Negrini, et al. · Alzheimer s & Dementia
PDF
Association of age with clinical progression across plasma p-tau217 levels
2026 · Ruyu Shi, Lamia T. Choity, et al. · medRxiv
PDF
Altered T1w/T2w-FLAIR Ratio in White Matter Hyperintensities as an Indicator of Structural Integrity Loss: Association with Alzheimer’s Disease and Vascular Dementia
2026 · Rushil Srirambhatla, Jacques-Yves Campion, et al. · medRxiv
PDF
Development of a Novel Blood‐Based Assay for Brain‐Derived Tau and Its Validation in Traumatic Brain Injury
2026 · Wasiu G. Balogun, Xuemei Zeng, et al. · Journal of Neurochemistry · 1
The dangers of data double dipping in assessing the classification accuracies of blood biomarkers in Alzheimer’s disease and related disorder research
2026 · Tianshu Liu, Xuemei Zeng, et al. · medRxiv
PDF
CNS-selective plasma p-tau217 accurately captures Alzheimer’s disease pathology and progression
2026 · Xuemei Zeng, Marissa F. Farinas, et al. · medRxiv · 2
PDF
2‐aminobutyrate mediates the impact of air pollution on blood biomarkers of Alzheimer's disease
2026 · Anum Saeed, Chris Mckennan, et al. · Alzheimer s & Dementia
Beyond Lipidation: CSF APOE4 Protein Burden, Not HDL Subclass, Drives Tau Associations in APOE4 Alzheimer’s Disease
2026 · Zoe E. Tsokolas, Isaac Asante, et al. · Research Square
PDF
Aβ‐ and tau‐associated neuroinflammatory signatures in Alzheimer's disease
2026 · Bruna Bellaver, Guilherme Povala, et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions
Plasma amyloid-β predicts amyloid-β accumulation in PET A- non-demented participants
2026 · Alexandra Gogola, Ann D. Cohen, et al. · Journal of Alzheimer s Disease · 2
Plasma brain-derived tau: analytical and clinical validation of the first commercial immunoassay
2026 · Michel N. Nafash, Sarah E. Svirsky, et al. · Scientific Reports · 7
PDF
Head-to-head comparison of plasma p-tau217 immunoassays for incipient Alzheimer’s disease in community cohorts
2026 · Rebecca A. Deek, Wasiu G. Balogun, et al. · Alzheimer s Research & Therapy · 2
Streamlined resource-efficient plasma amyloid-beta mass spectrometry assay has improved biomarker performance in preclinical Alzheimer’s disease
2026 · Yijun Chen, Xuemei Zeng, et al. · Nature Communications · 11
PDF
Plasma p-tau212 identifies cognitively unimpaired individuals with emerging amyloid-β pathology
2025 · Przemysław R. Kac, Armand González-Escalante, et al. · Journal of Neurology · 3
PDF
Impact of cardiometabolic factors and AD plasma biomarkers on white matter hyperintensities volume in individuals with cognitive complaints from the global south
2025 · Patricio Riquelme-Contreras, Fernando Henriquez, et al. · Neuroscience · 1
PDF
Clinical Validation of Novel Immunoassays for Plasma Phosphorylated Tau 217, 212, 181, 231, and Brain‐Derived Tau Across the Biochemical Spectrum of Alzheimer's Disease
2025 · Maciej Dulewicz, Przemysław Radosław Kac, et al. · Journal of Neurochemistry · 3
PDF
Plasma biomarkers, brain amyloid‐beta pathology, and cortical thickness in a non‐Hispanic White and Black/African American middle‐aged community cohort: The HCP‐CoBRA study
2025 · Shayna T. Brodman, Nicholas Heaton, et al. · Alzheimer s & Dementia · 1
PDF
Cross‐cohort validation and cutpoint estimation of the Janssen plasma p‐tau217+ assay in predominantly cognitively normal community studies
2025 · Wasiu G. Balogun, Xuemei Zeng, et al. · Alzheimer s & Dementia · 2
PDF
Association Between the Genetic Risk for Attention-Deficit/Hyperactivity Disorder and Cognitive Function in Older Age: The MYHAT Population-Based Study
2025 · Douglas Teixeira Leffa, Yingjin Zhang, et al. · American Journal of Geriatric Psychiatry · 3
PDF
Cross-cohort validation and cutpoint estimation of the Janssen plasma p-tau217+ assay in predominantly cognitively normal community cohorts
2025 · Wasiu G. Balogun, Xuemei Zeng, et al. · medRxiv
PDF
Amyloid beta and tau are associated with the dual effect of neuroinflammation on neurodegeneration
2025 · Guilherme Povala, Bruna Bellaver, et al. · Alzheimer s & Dementia · 22
CSF total tau as a proxy of synaptic degeneration
2025 · Carolina Soares, Bruna Bellaver, et al. · Nature Communications · 15
PDF
Arterial stiffness moderates the link between NfL and cognition: The IGNITE study
2025 · Amani M. Norling, Lewis A. Lipsitz, et al. · Alzheimer s & Dementia · 7
PDF
Plasma biomarkers identify brain ATN abnormalities in a dementia-free population-based cohort
2025 · Menayit Tamrat Dresse, Pamela C. L. Ferreira, et al. · Alzheimer s Research & Therapy · 10
PDF
Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer’s disease
2025 · Francieli Rohden, Pamela C. L. Ferreira, et al. · Nature Communications · 32
PDF
Year
Topic